CTOs on the Move

Medpace

www.medpace.com

 
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.medpace.com
  • 5375 Medpace Way
    Cincinnati, OH USA 45227
  • Phone: 513.579.9911

Executives

Name Title Contact Details
Austin LeMaster
Head Of Security Profile
Eric Strunk
Director Of Infrastructure, IT Support, and Information Security Profile
Brandon Ebken
Chief Information Officer Profile

Similar Companies

Cook Biotech / Biodesign

Cook Biotech / Biodesign is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Imaging Resources

Medical Imaging Resources, Inc. is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acclarent

Acclarent, Inc. is a medical technology company focused on designing, developing and commercializing technologies that address conditions affecting the ear, nose and throat (ENT). The Company focuses on commercializing its Balloon Sinuplasty devices,

Epocrates

Epocrates, Inc. is a provider of clinical information and decision support tools to healthcare professionals, as well as interactive information services to the healthcare industry. As of April 17, 2008, the Company has subscriber base of over 500,000

Elixir Medical

Elixir Medical Corporation, a privately-funded company based in Milpitas, California, develops next-generation platforms to treat coronary and peripheral artery disease that are designed to restore the adaptive remodeling and pulsatile motion capabilities of the blood vessel. The company`s mission is to transform the care of patients with heart and vascular disease through innovation.